Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke.

There is currently a stark therapeutic void in the treatment of evolving stroke. Although P-selectin is rapidly expressed by hypoxic endothelial cells in vitro, the functional significance of P-selectin expression in stroke remains unexplored. In order to identify the pathophysiological consequences of P-selectin expression and to identify P-selectin blockade as a potential new approach for the treatment of stroke, experiments were performed using a murine model of focal cerebral ischemia and reperfusion. Early P-selectin expression in the postischemic cerebral cortex was demonstrated by the specific accumulation of radiolabeled anti-murine P-selectin IgG, with the increased P-selectin expression localized to the ipsilateral cerebral microvascular endothelial cells by immunohistochemistry. In experiments designed to test the functional significance of increased P-selectin expression in stroke, neutrophil accumulation in the ischemic cortex of mice expressing the P-selectin gene (PS +/+) was demonstrated to be significantly greater than that in homozygous P-selectin-null mice (PS -/-). Reduced neutrophil influx was accompanied by greater postischemic cerebral reflow (measured by laser Doppler) in the PS -/- mice. In addition, PS -/- mice demonstrated smaller infarct volumes (5-fold reduction, P<.05) and improved survival compared with PS +/+ mice (88% versus 44%, P<.05). Functional blockade of P-selectin in PS +/+ mice using a monoclonal antibody directed against murine P-selectin also improved early reflow and stroke outcome compared with control mice, with reduced cerebral infarction volumes noted even when the blocking antibody was administered after occlusion of the middle cerebral artery. These data are the first to demonstrate a pathophysiological role for P-selectin in stroke and suggest that P-selectin blockade may represent a new therapeutic target in the treatment of stroke.

[1]  M. Hommel,et al.  Thrombolytic therapy with streptokinase in acute ischemic stroke. , 1996, The New England journal of medicine.

[2]  M Barinaga,et al.  Finding new drugs to treat stroke. , 1996, Science.

[3]  E. Connolly,et al.  Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. , 1996, Neurosurgery.

[4]  T. Mayadas,et al.  Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. , 1996, The Journal of clinical investigation.

[5]  A. Beaudet,et al.  Absence of trauma-induced leukocyte rolling in mice deficient in both P- selectin and intercellular adhesion molecule 1 , 1996, The Journal of experimental medicine.

[6]  G. Zoppo.  Acute stroke--on the threshold of a therapy? , 1995 .

[7]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[8]  J. Manson,et al.  Primary prevention of stroke. , 1995, The New England journal of medicine.

[9]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[10]  P. Kubes,et al.  Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. , 1995, The Journal of clinical investigation.

[11]  R. Rothlein,et al.  Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy , 1995, Neurology.

[12]  A. Beaudet,et al.  Sequential contribution of L- and P-selectin to leukocyte rolling in vivo , 1995, The Journal of experimental medicine.

[13]  D. Vestweber,et al.  Only simultaneous blocking of the L‐ and P‐selectin completely inhibits neutrophil migration into mouse peritoneum , 1994, European journal of immunology.

[14]  M. Moskowitz,et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.

[15]  C. Smith,et al.  P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow. , 1994, The American journal of physiology.

[16]  P. Ward,et al.  Role of selectins in local and remote tissue injury following ischemia and reperfusion. , 1994, The American journal of pathology.

[17]  A. Arbor,et al.  Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. , 1994, Circulation research.

[18]  G. D. del Zoppo,et al.  P‐Selectin and Intercellular Adhesion Molecule‐1 Expression After Focal Brain Ischemia and Reperfusion , 1994, Stroke.

[19]  D. Granger,et al.  Early mucosal and microvascular changes in feline intestinal transplants. , 1993, Gastroenterology.

[20]  T. Mayadas,et al.  Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice , 1993, Cell.

[21]  D. J. Knudsen,et al.  Mouse Strain Differences in Susceptibility to Cerebral Ischemia are Related to Cerebral Vascular Anatomy , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  A. M. Lefer,et al.  In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. , 1993, The Journal of clinical investigation.

[23]  P. Kochanek,et al.  Polymorphonuclear Leukocytes and Monocytes/Macrophages in the Pathogenesis of Cerebral Ischemia and Stroke , 1992, Stroke.

[24]  G. D. del Zoppo,et al.  Inhibition of Polymorphonuclear Leukocyte Adherence Suppresses No‐Reflow After Focal Cerebral Ischemia in Baboons , 1992, Stroke.

[25]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[26]  Rodger P. McEver,et al.  Rapid neutrophil adhesion to activated endothelium mediated by GMP-140 , 1990, Nature.

[27]  U. Dirnagl,et al.  Continuous Measurement of Cerebral Cortical Blood Flow by Laser—Doppler Flowmetry in a Rat Stroke Model , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  B. Grøgaard,et al.  Delayed Hypoperfusion after Incomplete Forebrain Ischemia in the Rat. The Role of Polymorphonuclear Leukocytes , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  P. Kochanek,et al.  Influence of granulocytopenia on canine cerebral ischemia induced by air embolism. , 1989, Stroke.

[30]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[31]  L. Pitts,et al.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. , 1986, Stroke.

[32]  P. Kochanek,et al.  Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. , 1986, Stroke.

[33]  G. Schmid-Schönbein,et al.  Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. , 1983, The American journal of pathology.

[34]  David E. Levy,et al.  Delayed postischemic hypoperfusion , 1979, Neurology.

[35]  R. Kloner,et al.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.

[36]  R. Reisfeld,et al.  Protein iodination with solid state lactoperoxidase. , 1974, Biochemistry.

[37]  M. Kowada,et al.  Cerebral ischemia. II. The no-reflow phenomenon. , 1968, The American journal of pathology.

[38]  E. Connolly,et al.  Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. , 1996, The Journal of clinical investigation.

[39]  M. Bednar,et al.  The role of neutrophils and platelets in a rabbit model of thromboembolic stroke. , 1991, Stroke.